These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2715006)

  • 1. Diagnosis of ovarian cancer with radiolabelled monoclonal antibodies: our experience using 131I-B72.3.
    Mansi L; Panza N; Lastoria S; Pacilio G; Salvatore M
    Int J Rad Appl Instrum B; 1989; 16(2):127-35. PubMed ID: 2715006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancer: preliminary report.
    Lastoria S; D'Amico P; Mansi L; Giordano GG; Rossiello R; Schlom J; Pace E; Panza N; Pacilio G; Salvatore M
    Nucl Med Commun; 1988 May; 9(5):347-56. PubMed ID: 2842708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma.
    Camera L; Del Vecchio S; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M
    Eur J Nucl Med; 1991; 18(4):269-73. PubMed ID: 2070805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization.
    Del Vecchio S; Camera L; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M
    Int J Rad Appl Instrum B; 1991; 18(1):85-7. PubMed ID: 2010311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative radioimmunodetection of ovarian cancer using monoclonal antibody B72.3 and a portable gamma-detecting probe.
    Bell J; Mojzisik C; Hinkle G; Derman H; Schlom J; Martin E
    Obstet Gynecol; 1990 Oct; 76(4):607-11. PubMed ID: 2216188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary study of radioimmunoimaging by 131I-COC183B2 monoclonal antibody in patients with epithelial ovarian cancer.
    Qian HN; Feng J; Cui H; Gao BS; Qin SL; Fu TY; Wei P; Fu ZY; Gao SM; Yang ZY
    Chin Med J (Engl); 1991 Feb; 104(2):109-13. PubMed ID: 1874008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-associated monoclonal antibodies for the diagnosis and assessment of ovarian cancer.
    Shepherd JH; Granowska M; Britton KE; Mather S; Epenetos AA; Ward BG; Slevin M
    Br J Obstet Gynaecol; 1987 Feb; 94(2):160-7. PubMed ID: 3828255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of three monoclonal antibodies to human ovarian epithelial adenocarcinomas.
    Qian HN; Feng J; Cui H; Fu TY; Wei P; Fu ZY
    Chin Med J (Engl); 1989 Nov; 102(11):839-43. PubMed ID: 2517724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A; Gorstein F; Ohuchi N; Szpak CA; Johnston WW; Schlom J
    J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer.
    Davies JO; Davies ER; Howe K; Jackson P; Pitcher E; Randle B; Sadowski C; Stirrat GM; Sunderland CA
    J R Soc Med; 1985 Nov; 78(11):899-905. PubMed ID: 3906119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report.
    Ashorn R; Ashorn P; Punnonen R; Pöyhönen L; Turjanmaa V; Koskinen M; Helle M; Uusitalo A; Pystynen P; Krohn K
    Ann Chir Gynaecol Suppl; 1985; 197():5-10. PubMed ID: 3863532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple and sensitive assay for determination of human anti-idiotypic anti-B72.3 antibodies, which is not affected by the presence of tumour-associated glycoprotein 72.
    Reinsberg J; Schmolling J; Ackermann D
    Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):237-44. PubMed ID: 8721411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of radioimmunoscintigraphy compared to computed tomography in the diagnosis and follow-up of primary ovarian carcinoma].
    Barzen G; Cordes M; Langer M; Friedman W; Mayr AC; Felix R
    Rofo; 1990 Jul; 153(1):85-91. PubMed ID: 2166319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.
    Roselli M; Hitchcock CL; Molinolo A; Milenic DE; Colcher D; Martin EW; Hinkle GH; Schlom J
    Anticancer Res; 1995; 15(3):975-84. PubMed ID: 7645989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancer.
    Haisma HJ; Moseley KR; Battaile AI; Griffiths TC; Zurawski VR; Knapp RC
    Int J Cancer Suppl; 1988; 2():109-13. PubMed ID: 3162437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
    Johnston WW
    Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36.
    Symonds EM; Perkins AC; Pimm MV; Baldwin RW; Hardy JG; Williams DA
    Br J Obstet Gynaecol; 1985 Mar; 92(3):270-6. PubMed ID: 3978057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.
    Simpson J; Schlom J
    Yale J Biol Med; 1988; 61(4):351-66. PubMed ID: 3055701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.